Skip to main content
Log in

Hospitalization Drug Regimen Changes in Geriatric Patients and Adherence to Modifications by General Practitioners in Primary Care

  • Published:
The journal of nutrition, health & aging

Abstract

Objectives

To evaluate the overall rate of adherence by general practitioners (GPs) to treatment modifications suggested at discharge from hospital and to assess the way communication between secondary and primary care could be improved.

Design

Observational prospective cohort study.

Setting

Patients hospitalized from the emergency department to the acute geriatric care unit of a university hospital.

Participants

206 subjects with a mean age of 85 years.

Measurements

Changes in drug regimen undertaken during hospitalization were collected with the associated justifications. Adherence at one month by GPs to treatment modifications was assessed as well as modifications implemented in primary care with their rationale in case of non-adherence. Community pharmacists’ and GPs’ opinions about quality of communication and information transfer at hospital-general practice interface were investigated.

Results

5.5 ± 2.8 drug regimen changes were done per patient during hospitalization. The rate of adherence by GPs to treatment modifications suggested at discharge from hospital was 83%. In most cases, non-adherence by GPs to treatment modifications done during hospitalization was due to dosage adjustments, symptoms resolution but also worsening of symptoms. The last of which was particularly true for psychotropic drugs. All GPs received their patients’ discharge letters but the timely dissemination still needs to be improved. Only 6.6% of community pharmacists were informed of treatment modifications done during their patients’ hospitalization.

Conclusion

Our findings showed a successful rate of adherence by GPs to treatment modifications suggested at discharge from hospital, due to the fact that optimization was done in a collaborative way between geriatricians and hospital pharmacists and that justifications for drug regimen changes were systematically provided in discharge letters. Communication processes at the interface between secondary and primary care, particularly with community pharmacists, must be strengthened to improve seamless care.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C, et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet Lond Engl. 2007 Jul 14;370(9582):173–84.

    Article  Google Scholar 

  2. Cornish PL, Knowles SR, Marchesano R, Tam V, Shadowitz S, Juurlink DN, et al. Unintended medication discrepancies at the time of hospital admission. Arch Intern Med. 2005 Feb 28;165(4):424–9.

    Article  PubMed  Google Scholar 

  3. Vira T, Colquhoun M, Etchells E. Reconcilable differences: correcting medication errors at hospital admission and discharge. Qual Saf Health Care. 2006 Apr;15(2):122–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Coleman EA, Smith JD, Raha D, Min S. Posthospital medication discrepancies: prevalence and contributing factors. Arch Intern Med. 2005 Sep 12;165(16):1842–7.

    Article  PubMed  Google Scholar 

  5. Forster AJ, Clark HD, Menard A, Dupuis N, Chernish R, Chandok N, et al. Adverse events among medical patients after discharge from hospital. CMAJ Can Med Assoc J J Assoc Medicale Can. 2004 Feb 3;170(3):345–9.

    Google Scholar 

  6. Institute of Medicine Retooling for an Aging America: Building the Health Care Workforce. Washington, DC: The National Academies Press, 2008.

  7. Viktil KK, Blix HS, Eek AK, Davies MN, Moger TA, Reikvam A. How are drug regimen changes during hospitalisation handled after discharge: a cohort study. BMJ Open. 2012;2(6).

  8. Cool C, Cestac P, Laborde C, Lebaudy C, Rouch L, Lepage B, et al. Potentially inappropriate drug prescribing and associated factors in nursing homes. J Am Med Dir Assoc. 2014;15(11):850.e1-9.

    Article  PubMed  Google Scholar 

  9. Récoché I, Lebaudy C, Cool C, Sourdet S, Piau A, Lapeyre-Mestre M, et al. Potentially inappropriate prescribing in a population of frail elderly people. Int J Clin Pharm. 2016 Dec 10

    Google Scholar 

  10. Laroche M-L, Charmes J-P, Merle L. Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol. 2007 Aug;63(8):725–31.

    Article  PubMed  Google Scholar 

  11. Gallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D. STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008 Feb;46(2):72–83.

    Article  CAS  PubMed  Google Scholar 

  12. Allenet B, Bedouch P, Rose F-X, Escofier L, Roubille R, Charpiat B, et al. Validation of an instrument for the documentation of clinical pharmacists’ interventions. Pharm World Sci PWS. 2006 Aug;28(4):181–8.

    Article  PubMed  Google Scholar 

  13. Haute Autorité de Santé. Recommandations de bonne pratique clinique chez les sujets âgés. Available from: http://www.has-sante.fr/portail/jcms/c_39085/fr/recherche?portlet=c_39085&text=personnes+ag%C3%A9es&opSearch=&lang=fr

  14. Kruse W, Rampmaier J, Frauenrath-Volkers C, Volkert D, Wankmüller I, Micol W, et al. Drug-prescribing patterns in old age. A study of the impact of hospitalization on drug prescriptions and follow-up survey in patients 75 years and older. Eur J Clin Pharmacol. 1991;41(5):441–7.

    CAS  PubMed  Google Scholar 

  15. Grimmsmann T, Schwabe U, Himmel W. The influence of hospitalisation on drug prescription in primary care—a large-scale follow-up study. Eur J Clin Pharmacol. 2007 Aug;63(8):783–90.

    Article  PubMed  Google Scholar 

  16. Himmel W, Kochen MM, Sorns U, Hummers-Pradier E. Drug changes at the interface between primary and secondary care. Int J Clin Pharmacol Ther. 2004 Feb;42(2):103–9.

    Article  CAS  PubMed  Google Scholar 

  17. Hayes BD, Klein-Schwartz W, Barrueto F. Polypharmacy and the geriatric patient. Clin Geriatr Med. 2007 May;23(2):371–390, vii.

    Article  PubMed  Google Scholar 

  18. Autier P, Boniol M, Pizot C, Mullie P. Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol. 2014 Jan;2(1):76–89.

    Article  CAS  PubMed  Google Scholar 

  19. Sheen E, Triadafilopoulos G. Adverse effects of long-term proton pump inhibitor therapy. Dig Dis Sci. 2011 Apr;56(4):931–50.

    Article  CAS  PubMed  Google Scholar 

  20. Schäfers A, Martini N, Moyes S, Hayman K, Zolezzi M, McLean C, et al. Medication use in community-dwelling older people: pharmacoepidemiology of psychotropic utilisation. J Prim Health Care. 2014 Dec;6(4):269–78.

    PubMed  Google Scholar 

  21. Sinclair A, Morley JE, Rodriguez-Mañas L, Paolisso G, Bayer T, Zeyfang A, et al. Diabetes mellitus in older people: position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diabetes. J Am Med Dir Assoc. 2012 Jul;13(6):497–502.

    Article  PubMed  Google Scholar 

  22. Renom-Guiteras A, Meyer G, Thürmann PA. The EU(7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries. Eur J Clin Pharmacol. 2015 Jul;71(7):861–75.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Hogan DB. Long-term efficacy and toxicity of cholinesterase inhibitors in the treatment of Alzheimer disease. Can J Psychiatry Rev Can Psychiatr. 2014 Dec;59(12):618–23.

    Article  Google Scholar 

  24. Société Française d’Hypertension Artérielle. Prise en charge de l’hypertension artérielle de l’adulte. Recommandations [Internet]. 2013 [cited 2016 Sep 22]. Available from: http://www.sfhta.eu/wp-content/uploads/2012/12/Recommandation-SFHTA-2013-Prise-en-charge-HTA-de-lAdulte.pdf

    Google Scholar 

  25. Zermansky AG, Alldred DP, Petty DR, Raynor DK, Freemantle N, Eastaugh J, et al. Clinical medication review by a pharmacist of elderly people living in care homes— randomised controlled trial. Age Ageing. 2006 Nov;35(6):586–91.

    Article  PubMed  Google Scholar 

  26. Haute Autorité de Santé. Arrêt des benzodiazépines et médicaments apparentés: démarche du médecin traitant en ambulatoire. [Internet]. 2015 [cited 2016 Sep 25]. Available from: http://www.has-sante.fr/portail/upload/docs/application/pdf/2015-06/fiche_memo_arret_benzodiazepines_pour_mel_2015_06_16.pdf

  27. Vega A. Le partage des responsabilités en médecine. Une approche socioanthropologique des pratiques soignantes. [Internet]. 2011 [cited 2016 Sep 25]. Available from: http://www.formindep.org/IMG/pdf/rapport_final3.pdf

    Google Scholar 

  28. Clerc P, Le Breton J, Mousquès J, Hebbrecht G, De Pouvourville G. Les enjeux du traitement médicamenteux des patients atteints de polypathologies. Résultats de l’étude expérimentale Polychrome. 2010 Juillet-août;156.

    Google Scholar 

  29. Urban R, Paloumpi E, Rana N, Morgan J. Communicating medication changes to community pharmacy post-discharge: the good, the bad, and the improvements. Int J Clin Pharm. 2013 Oct;35(5):813–20.

    Article  PubMed  Google Scholar 

  30. Bolas H, Brookes K, Scott M, McElnay J. Evaluation of a hospital-based community liaison pharmacy service in Northern Ireland. Pharm World Sci PWS. 2004 Apr;26(2):114–20.

    Article  PubMed  Google Scholar 

  31. Brookes K, Scott MG, McConnell JB. The benefits of a hospital based community services liaison pharmacist. Pharm World Sci PWS. 2000 Apr;22(2):33–8.

    Article  CAS  PubMed  Google Scholar 

  32. Munday A, Kelly B, Forrester JW, Timoney A, McGovern E. Do general practitioners and community pharmacists want information on the reasons for drug therapy changes implemented by secondary care? Br J Gen Pract J R Coll Gen Pract. 1997 Sep;47(422):563–6.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Laure Rouch.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rouch, L., Farbos, F., Cool, C. et al. Hospitalization Drug Regimen Changes in Geriatric Patients and Adherence to Modifications by General Practitioners in Primary Care. J Nutr Health Aging 22, 328–334 (2018). https://doi.org/10.1007/s12603-017-0940-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12603-017-0940-1

Key words

Navigation